Oral Typhoid Vaccine Market Synopsis:<\/p>\n
Oral Typhoid Vaccine Market Size Was Valued at USD 127.10 Million in 2023, and is Projected to Reach USD 363.95 Million by 2032, Growing at a CAGR of 12.40% From 2024-2032.<\/p>\n
Oral typhoid vaccine industry involves the manufacturing, supply and utilization or oral vaccines that protects the body against typhoid fever. These vaccines are taken orally and are of live attenuated or inactivated of Salmonella typhi, which is rather effective form of immunization in endemic areas. <\/p>\n
Increasing incidence rates of typhoid fever in developing nations \u2013 especially in the Asia-Pacific and African regions \u2013 are also a key factor for the oral typhoid vaccine market. Typhoid fever is still common in regions where sanitation is weak and there is no access to clean water, thus massive vaccination is essential. States and global health businesses are concerned with mass vaccination to reduce the prevalence of the disease.<\/p>\n
To start with, the oral typhoid vaccines have enhanced vaccine acceptance and compliance, due to the ease of administration, and longer shelf life. Specific improvement in live attenuated vaccine strains offering prolonged immunity has improved acceptability of these products. Higher funding for vaccine development as well as for expanding cold chain facility also help to drive the market growth.<\/p>\n
Oral Typhoid Vaccine Market Trend Analysis:<\/p>\n
Shift Toward Preventive Healthcare<\/p>\n
OPV has been used to deliver, and many countries have incorporated this vaccine into their regular immunization schedule in order to achieve community-wide immunity, particularly in affected MTS. This trend is especially favorite in India and Bangladesh where typhoid fever is a severe problem. This integration is expected to increase the use of vaccines and at the same time decrease health care expenses.<\/p>\n
With a focus toward the delivery of preventive healthcare services across the global, oral typhoid vaccines have gained widespread acceptance. It is attributed to higher awareness campaigns, improved and enhanced access to health care services, and concerted attempts being made to reduce the cost impact of the typhoid outbreaks. UNICEF and WHO are important in the provision of vaccines in hard to reach areas.<\/p>\n
Growth in Travel and Tourism Markets<\/p>\n
Again, the LMICs remain the most attractive region with high growth projection in the oral typhoid vaccines market. Immunization campaigns in these regions are backed by organizations such as Gavi, the Vaccine Alliance and by philanthropic money Available online. The governments and private organizations are expanding investments to make the vaccine affordable and available throughout the developing region.<\/p>\n
Due to the expansion of global tourism to areas with typhoid fever, the need for oral typhoid vaccines has become even higher. These vaccines are experiencing higher demand in travel clinics and pharmacies since tourists as well as expatriates do not wish to be ill during their travel. This means that vaccine manufacturers have a gold mine when it comes to the shots for the travellers from around the world.<\/p>\n
Oral Typhoid Vaccine Market Segment Analysis:<\/p>\n
Oral Typhoid Vaccine Market is Segmented on the basis of Type, Age Group, Application, End User, and Region.<\/p>\n
By Type, Live Attenuated Vaccines segment is expected to dominate the market during the forecast period<\/p>\n
The market has been divided into live attenuated and inactivated vaccines. Suspended live vaccines are produced from decreasing types of Salmonella typhi offering long-lasting immunization in a single application. Inactivated vaccines, in their turn, use killed bacteria, which is useful for immunoexpressed persons or for those who should not use live preparations.<\/p>\n
By Application, Prevention in Endemic Areas segment expected to held the largest share <\/p>\n
The application segment includes prevention in endemic as well as non-endemic application. In endemic areas, the oral typhoid vaccines form important preventive measures that are administered through mass immunisation to control the spread of the disease. In non-endemic countries, they are used in people likely to travel or work in high risk countries as a precaution against the illness.<\/p>\n
Oral Typhoid Vaccine Market Regional Insights: <\/p>\n
Asia pacific is Expected to Dominate the Market Over the Forecast period <\/p>\n
The Asia-Pacific region stands as the largest market for oral typhoid vaccines because it is a region most affected by typhoid fever. Like India, Bangladesh & Indonesia the disease prevalence rate is high which also results into large population coverage of vaccines. In these region governments work with the international organizations for funding and carrying out large scale immunization activities.<\/p>\n
In addition, the high population density of the region and often high population density together with the low level of sanitation facilities make oral typhoid vaccines necessary. Asian-Pacific manufactures also increase market growth by manufacturing cheap vaccines to help the population get better access.<\/p>\n
Active Key Players in the Oral Typhoid Vaccine Market <\/p>\n
Bharat Biotech (India)<\/p>\n
Bio-Med (India)<\/p>\n
Emergent BioSolutions (USA)<\/p>\n
GlaxoSmithKline (UK)<\/p>\n
PaxVax (USA)<\/p>\n
Sanofi (France)<\/p>\n
Serum Institute of India (India)<\/p>\n
Shanghai Institute of Biological Products (China)<\/p>\n
Sinovac Biotech (China)<\/p>\n
Zydus Cadila (India)<\/p>\n
Other Active Players.<\/p>\n","protected":false},"excerpt":{"rendered":"
Oral typhoid vaccine industry involves the manufacturing, supply and utilization or oral vaccines that protects the body against typhoid fever.<\/p>\n","protected":false},"featured_media":6184,"template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[194],"product_tag":[],"class_list":["post-9557","product","type-product","status-publish","has-post-thumbnail","product_cat-healthcare-life-sciences","first","instock","virtual","purchasable","product-type-simple"],"acf":[],"yoast_head":"\n